EICHOR
● Active Not Recruiting
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Complement Inhibitors
Condition: Paroxysmal Nocturnal Hemoglobinuria · Sponsor: Hoffmann-La Roche
About this study
A study designed to evaluate the safety of crovalimab with eculizumab in participants with PNH currently treated with complement inhibitors. This study will enroll approximately 190 participants.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (80)
| Carolinas Healthcare System | Charlotte, North Carolina, United States | — |
| Nationwide Children's Hospital | Columbus, Ohio, United States | — |
| Cliniques Universitaires Saint-Luc | Brussels, Belgium | — |
| AZ Delta Campus Westlaan | Roeselare, Belgium | — |
| Chronos Pesquisa Clinica | Taguatinga, Federal District, Brazil | — |
| Santa Casa de Misericordia de Porto Alegre | Porto Alegre, Rio Grande do Sul, Brazil | — |
| Hospital de Clínicas de Porto Alegre X | Porto Alegre, Rio Grande do Sul, Brazil | — |
| Instituto Joinvilense de Hematologia E Oncologia | Joinville, Santa Catarina, Brazil | — |
| Hospital das Clínicas FMRP-USP | Ribeirão Preto, São Paulo, Brazil | — |
| *X*CEPHO - Centro de Estudos e Pesquisas em Hematologia e Oncologia | Santo André, São Paulo, Brazil | — |
| Hospital Sírio-Libanês | São Paulo, São Paulo, Brazil | — |
| Hospital Paulistano | São Paulo, São Paulo, Brazil | — |
+ 68 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.